Prescriber is the leading UK journal for healthcare professionals focussing on prescribing and medicines management. The journal features articles on all areas of therapeutics and prescribing policy and is fully peer reviewed. The content is relevant and of interest to all prescribers and prescribing policy makers including GPs, pharmacists, nurses and hospital specialists. Access to all content is free to healthcare professionals following registration.Sign up for e-alerts and print copies

Latest News

NICE drafts guidance on acute cough

NICE’s proposed guidance for minimising antibiotic prescribing for acute cough attracted the attention of the lay media with the publication of its draft...Read more

Obesity and diabetes in the spotlight again

The incidence of stroke and heart attack associated with diabetes will increase by 29% within the next 20 years, the British Heart Foundation (BHF) has...Read more

GPs should be told about controlled drug prescribing

Prescribers should ask patients about their other medication and “where possible” inform the patient’s GP when they prescribe a controlled drug, the Care...Read more

Novel analgesic effective for osteoarthritis pain

Tanezumab, a monoclonal antibody targeted against nerve growth factor, is effective in the treatment of moderate to severe pain associated with osteoarthritis,...Read more

Cognitive behavioural therapy effective for IBS

NICE guidance on the management of irritable bowel syndrome (IBS) recommends referral for psychological interventions such as cognitive behavioural therapy...Read more

Featured Articles

Are patients taking pot luck with cannabis?
In July, Home Secretary Sajid Javid decided to reschedule cannabis-derived medicinal products to allow them to be legally prescribed by specialist clinicians. But while there is some scientific evidence supporting the use of cannabinoids in certain medical conditions, more research is needed to determine the full risks and benefits.
Click here to view

Recommended drug therapies for inflammatory bowel disease
The treatment of inflammatory bowel disease (ulcerative colitis and Crohn’s disease) has been revolutionised in recent years with the advent of biological therapies. This article discusses the current role of both conventional and biological treatments in the management of these conditions.
Click here to view

Online consultations: the future of NHS GP appointments?
In 2016, the General Practice Forward View invested £45 million in a national programme to support uptake of online consultation systems in every GP practice. This article examines the progress that has been made so far, and whether this new way of working is proving popular with health professionals and patients.
Click here to view

Web design and marketing agency Leamington Spa